Except as provided in subparagraph (B), if an approval of an application filed under subsection (b) is in effect with respect to a particular use or intended use of a new animal drug, the drug shall not be deemed unsafe for the purposes of paragraph (1) and shall be exempt from the requirements of section 502(f) with respect to a different use or intended use of the drug, other than a use in or on animal feed, if such use or intended use (i) is by or on the lawful written or oral order of a licensed veterinarian within the context of a veterinarianclientpatient relationship, as defined by the Secretary; and (ii) is in compliance with regulations promulgated by the Secretary that establish the conditions for such different use or intended use. (5) If the approval of an application filed under section 505 is in effect, the drug under such application shall not be deemed unsafe for purposes of paragraph (1) and shall be exempt from the requirements of section 502(f) with respect to a use or intended use of the drug in animals if such use or intended use (A) is by or on the lawful written or oral order of a licensed veterinarian within the context of a veterinarianclientpatient relationship, as defined by the Secretary; and (B) is in compliance with regulations promulgated by the Secretary that establish the conditions for the use or intended use of the drug in animals. The Secretary may by general regulation provide access to the records of veterinarians to ascertain any use or intended use authorized under subparagraph (A) that the Secretary has determined may present a risk to the public health. Regulations under clause (ii) may prohibit particular uses of an animal drug and shall not permit such different use of an animal drug if the labeling of another animal drug which contains the same active ingredient and which is in the same dosage form and concentration provides for such different use. (B) If the Secretary finds that there is a reasonable probability that a use of an animal drug authorized under subparagraph (A) may present a risk to the public health, the Secretary may (i) establish a safe level for a residue of an animal drug when it is used for such different use authorized by subparagraph (A); and (ii) require the development of a practical, analytical method for the detection of residues of the drug above the safe level established under clause (i). (2) Section 512(e).Section 512(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b(e) is amended in subparagraph (A), by inserting before the semicolon the following: or the condition of use authorized under subsection (a)(4)(A). SECTION 1.